ESC 365 - Combined therapy of SGLT2i and GLP1ra reduces all-cause mortality in diabetic patients with a higher impact on women

Delegates Premium Access

Combined therapy of SGLT2i and GLP1ra reduces all-cause mortality in diabetic patients with a higher impact on women

Session: Protecting the female heart life-long

Topic: Cardiovascular Disease in Women

Speaker: Doctor D. Garcia Vega (Santiago de Compostela, ES)

Event: ESC Preventive Cardiology 2025

Congress Presentation

Add to my library

About the speaker

Doctor David Garcia Vega

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)

0 follower

3 more presentations in this session

Gender differences in prevalence and management of hypertension in Switzerland from 1997 to 2022

Speaker: Doctor S. Yi (Lausanne, CH)

Evaluation of the age-related prevalence of cardiovascular risk factors to guide systematic long-term follow-up after preeclampsia

Speaker: Mrs G. Jansen (Maastricht, NL)

Earlier menopause is related to adverse left ventricular morphology and function in the UK Biobank

Speaker: Doctor J. Marino (Greifswald, DE)

Access the full session

Protecting the female heart life-long

Speakers: Doctor D. Garcia Vega, Doctor S. Yi, Mrs G. Jansen, Doctor J. Marino

About the event

ESC Preventive Cardiology 2025

3 April - 5 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources